Not sure the statistics agree with you on that .... especially given another 1,847 people died on Tuesday 4th Jan from COVID-19 in the USA alone ?
The Doc the other day claimed that numbers were decreasing, which I disagreed with ...... compare the above post snippet with the below statistics for Tuesday 8th February 2022
One month on from the original post and this substantial increase in COVID-19 daily deaths IMO would validate the need for the additional Remestemcel-L phase 3 trial for COVID-19 ARDS and sadly demonstrates that there would be ample available patients for recruitment ... That said, I am the first to admit that it needs to be funded by someone else like the NIH or the 'partner' SI eluded to in the Edison video presentation if that is not the NIH .....
Just hurry up already .... these sorts of daily death numbers are unacceptable IMO
https://www.worldometers.info/coronavirus/
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-202
-
- There are more pages in this discussion • 704 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |